James Zavoral is a Cardiology physician affiliated with Fairview Southdale Hospital. OpenAlex indexes 24 publications with 911 citations (h-index 10); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
Sponsor: Veloxis Pharmaceuticals
- Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
Sponsor: Veloxis Pharmaceuticals
- The Effect of Betahistine on Body Weight in Obese Subjects
Sponsor: OBEcure Ltd.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.3%Cholesterol absorption inhibitor21.9%Ezetimibe100%Part D≥48 patientsStatin20.9%Rosuvastatin Calcium51%Atorvastatin Calcium39%Simvastatin11%Part D<11 patients+ 7 more classes in this area
Genitourinary & hormones
3.8%alpha-Adrenergic Blocker3.8%Tamsulosin Hcl100%Part D<11 patientsBlood & clotting
3.7%Factor Xa inhibitor3.7%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”